Medicinal Products

Theraflu Max 1000 mg/12,2 mg/200 mg prašak za oralnu otopinu

Name Theraflu Max 1000 mg/12,2 mg/200 mg prašak za oralnu otopinu
Marketing Authorisation Number HR-H-102729071
Active Substance paracetamol
fenilefrinklorid
gvaifenezin
Composition svaka jednodozna vrećica sadrži 1000 mg paracetamola, 12,2 mg fenilefrinklorida (što odgovara 10 mg fenilefrin baze) i 200 mg gvaifenezina
Pharmaceutical Form prašak za oralnu otopinu
Packaging [MA Number for Packaging] 10 vrećica s praškom, u kutiji  [HR-H-102729071-01]
Manufacturer GlaxoSmithKline Consumer Healtcare GmbH & Co. KG, München, Njemačka
Haleon Germany GmbH, München, Njemačka
Marketing Authorisation Holder GlaxoSmithKline Dungarvan Ltd., Knockbrack, Dungarvan, County Waterford, Irska
Marketing Authorisation Date 06.08.2021
MA Period of Validity unlimited
Classification Number UP/I-530-09/20-02/52
Registration Number 381-12-01/38-21-03
Prescription bez recepta
Distribution u ljekarni
Advertising to general public dopušteno
ATC Code N02BE51
Medicinal product marketed in the Croatia Da
SmPC download
PL download
Public Assessment Report download
Back